{"id":876,"date":"2026-04-23T23:49:28","date_gmt":"2026-04-23T23:49:28","guid":{"rendered":"https:\/\/decodepeptides.com\/?product=igf-1-lr3-1mg"},"modified":"2026-05-29T01:10:58","modified_gmt":"2026-05-29T01:10:58","slug":"igf-1-lr3-1mg","status":"publish","type":"product","link":"https:\/\/decodepeptides.com\/de\/product\/igf-1-lr3-1mg\/","title":{"rendered":"IGF-1 LR3 1 mg"},"content":{"rendered":"<p><strong>IGF-1 LR3<\/strong> (Insulin-like Growth Factor-1 Long R3) is a recombinant analogue of endogenous IGF-1 with an N-terminal methionine extension and a glutamic acid\u2192arginine substitution at position 3. This R3 modification reduces binding affinity to IGF-binding proteins (IGFBP-1 through -6) by over 1000-fold, extending the plasma half-life from ~12 minutes to <strong>20\u201330 Stunden<\/strong> and dramatically increasing bioavailability at peripheral tissue receptors. It is the preferred research tool for studying mTOR-driven protein synthesis, muscle satellite cell biology, anti-catabolic mechanisms, and neurotrophy \u2014 independently of hepatic IGFBP sequestration.<\/p>\n<div class=\"dp-product-info\">\n<div class=\"dp-stats-row\">\n<div class=\"dp-stat\"><span class=\"dp-stat-num\">\u226599%<\/span><span class=\"dp-stat-label\">HPLC-Reinheit<\/span><\/div>\n<div class=\"dp-stat\"><span class=\"dp-stat-num\">1mg<\/span><span class=\"dp-stat-label\">Von Vial<\/span><\/div>\n<div class=\"dp-stat\"><span class=\"dp-stat-num\">30+<\/span><span class=\"dp-stat-label\">Jahre der Recherche<\/span><\/div>\n<div class=\"dp-stat\"><span class=\"dp-stat-num\">83 aa<\/span><span class=\"dp-stat-label\">Struktur<\/span><\/div>\n<\/div>\n<div class=\"dp-info-images\"><img decoding=\"async\" src=\"https:\/\/decodepeptides.com\/wp-content\/uploads\/2026\/04\/peptide-info\/igf1-info-1.jpg\" alt=\"IGF-1 LR3 1mg research data 1\" loading=\"lazy\"><img decoding=\"async\" src=\"https:\/\/decodepeptides.com\/wp-content\/uploads\/2026\/04\/peptide-info\/igf1-info-2.jpg\" alt=\"IGF-1 LR3 1mg research data 2\" loading=\"lazy\"><\/div>\n<p><span class=\"dp-section-label\">Forschungsdaten<\/span><\/p>\n<h2>Research Snapshot \u2014 IGF-1 LR3<\/h2>\n<h3>Schl\u00fcsselmechanismen und Signalwege<\/h3>\n<ul class=\"dp-pathway-list\">\n<li><strong>PI3K \u2192 Akt \u2192 mTORC1<\/strong>Phosphorylates S6K1 and 4E-BP1 \u2014 the two rate-limiting steps in ribosomal biogenesis and protein translation initiation.<\/li>\n<li><strong>Ras \u2192 MEK \u2192 ERK<\/strong>Drives G1\u2192S cell cycle progression via cyclin D1; regulates DNA replication and myoblast differentiation.<\/li>\n<li><strong>FOXO Suppression<\/strong>Akt phosphorylates FOXO1\/3a, preventing transcription of atrophy genes MuRF1 and Atrogin-1 \u2014 blocking muscle proteolysis.<\/li>\n<li><strong>Satellite Cell Activation<\/strong>IGF-1R on muscle stem cells drives proliferation and differentiation into new myofibres \u2014 adding myonuclei.<\/li>\n<li><strong>IGFBP-3 Bypass<\/strong>R3 substitution reduces IGFBP binding affinity by &gt;1000\u00d7, extending half-life from 12 min to 20\u201330 hours.<\/li>\n<li><strong>Neurotrophy<\/strong>Promotes neuron survival, axonal regeneration and oligodendrocyte differentiation in CNS injury models.<\/li>\n<\/ul>\n<h3>Zusammenfassung der pr\u00e4klinischen und klinischen Forschung<\/h3>\n<table class=\"dp-research-table\">\n<thead>\n<tr>\n<th>Forschungsgebiet<\/th>\n<th>Wichtigste Erkenntnis<\/th>\n<th>Quelle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Muscle Hypertrophy<\/td>\n<td>+25% muscle mass in 7 days via local injection in rat hindlimb \u2014 without systemic GH.<\/td>\n<td>Coleman ME et al., 1995 \u2014 J Biol Chem<\/td>\n<\/tr>\n<tr>\n<td>Satellite Cell Activation<\/td>\n<td>3.5\u00d7 satellite cell proliferation vs. native IGF-1 at equal molar doses in human myoblasts.<\/td>\n<td>Foulstone EJ et al., 2003 \u2014 J Cell Physiol<\/td>\n<\/tr>\n<tr>\n<td>Anti-Catabolism<\/td>\n<td>Significantly attenuated muscle protein catabolism and nitrogen loss in burn injury models.<\/td>\n<td>Herndon DN et al., 1999 \u2014 Ann Surg<\/td>\n<\/tr>\n<tr>\n<td>Neuronal Survival<\/td>\n<td>Neurotrophic \u2014 extended half-life optimal for ALS, neuropathy and axonal regeneration models.<\/td>\n<td>Ishii DN et al., 1994<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div class=\"dp-references\">\n<h3>Referenzen<\/h3>\n<ol>\n<li>Coleman ME et al. &#8220;Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy.&#8221; <em>J Biol Chem<\/em>, 1995;270(20):12109\u201312116.<\/li>\n<li>LeRoith D et al. &#8220;The role of the insulin-like growth factor-I receptor in cancer.&#8221; <em>Ann N Y Acad Sci<\/em>, 2003;995:58\u201368.<\/li>\n<li>Foulstone EJ et al. &#8220;Role of insulin-like growth factor binding protein-3 in the insulin-like growth factor axis of human skeletal muscle.&#8221; <em>J Cell Physiol<\/em>, 2003;196(2):229\u2013240.<\/li>\n<li>Singleton JR et al. &#8220;Insulin-like growth factor I signaling in motor neuron disease.&#8221; <em>Brain Res<\/em>, 2000;888(2):241\u2013248.<\/li>\n<\/ol>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>IGF-1 LR3 (Insulin\u00e4hnlicher Wachstumsfaktor-1 Long R3) ist ein synthetisches Analogon des endogenen IGF-1. Es wurde mit einer 83 Aminos\u00e4uren langen Sequenz entwickelt, die eine 13 Aminos\u00e4uren lange N-terminale Verl\u00e4ngerung und eine Arginin-Substitution an Position 3 aufweist. Diese Modifikationen verl\u00e4ngern die Halbwertszeit und erh\u00f6hen die Wirksamkeit im Vergleich zu nativem IGF-1 signifikant. Jede Durchstechflasche enth\u00e4lt 1 mg IGF-1 LR3 in Forschungsqualit\u00e4t.<\/p>","protected":false},"featured_media":2119,"comment_status":"open","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"product_brand":[],"product_cat":[57],"product_tag":[212,233,234,256,231,222,254,232,255,206],"class_list":["post-876","product","type-product","status-publish","has-post-thumbnail","product_cat-growth-performance","product_tag-angiogenesis","product_tag-bone-density","product_tag-gh-axis","product_tag-hplc-verified","product_tag-igf-1","product_tag-insulin-sensitivity","product_tag-lyophilized-powder","product_tag-muscle-growth","product_tag-research-grade","product_tag-tissue-repair","first","instock","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/product\/876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/comments?post=876"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/media\/2119"}],"wp:attachment":[{"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/media?parent=876"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/product_brand?post=876"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/product_cat?post=876"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/product_tag?post=876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}